急性A型主动脉夹层术前灌注不良对早期和晚期死亡率的影响:北欧急性A型主动脉夹层联盟更新
基于北欧急性A型主动脉夹层(ATAAD)注册研究1159例手术患者,术前灌注不良发生率为33%。灌注不良患者30天死亡率为28.9%,无灌注不良者为12.1%;任何灌注不良均为30天和晚期死亡的独立预测因素。
要点
- 术前灌注不良在ATAAD手术患者中发生率为33%。
- 灌注不良患者30天死亡率28.9%,无灌注不良者12.1%。
- 任何灌注不良均独立预测30天和晚期死亡。
核心结论
- 术前灌注不良显著影响ATAAD手术的早期和晚期结局,其管理仍是降低手术相关死亡率的主要挑战。
研究设计与样本
- 基于北欧急性A型主动脉夹层注册研究,纳入2005年1月至2014年12月8个北欧中心1159例ATAAD手术患者,采用多因素logistic回归和Cox回归分析。
主要发现
- 术前灌注不良见于381/1159例(33%)患者,其30天死亡率为28.9%,无灌注不良者为12.1%。
- 30天死亡的独立预测因素包括任何灌注不良(OR 2.76,95%CI 1.94-3.93)、心脏灌注不良(OR 2.37,95%CI 1.34-4.17)、肾脏灌注不良(OR 2.38,95%CI 1.23-4.61)和外周灌注不良(OR 1.95,95%CI 1.26-3.01)。
- 晚期死亡的预测因素包括任何灌注不良(HR 1.72,95%CI 1.21-2.43)、心脏灌注不良(HR 1.89,95%CI 1.24-2.87)和胃肠道灌注不良(HR 2.25,95%CI 1.18-4.26)。
- 灌注不良与1年、3年和5年生存率显著降低相关(95.0%±0.9% vs 88.7%±1.9%、90.1%±1.3% vs 84.0%±2.4%、85.4%±1.7% vs 80.8%±2.7%;log rank P=.009)。
临床怎么用
- 对ATAAD患者应术前评估灌注不良状态,识别心脏、肾脏、外周及胃肠道灌注不良以进行风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the effect of preoperative malperfusion on 30-day and late mortality and postoperative complications using data from the Nordic Consortium for Acute Type A Aortic Dissection (ATAAD) registry. METHODS: We studied 1159 patients who underwent ATAAD surgery between January 2005 and December 2014 at 8 Nordic centers. Multivariable logistic and Cox regression analyses were performed to identify independent predictors of 30-day and late mortality. RESULTS: Preoperative malperfusion was identified in 381 of 1159 patients (33%) who underwent ATAAD surgery. Thirty-day mortality was 28.9% in patients with preoperative malperfusion and 12.1% in those without. Independent predictors of 30-day mortality included any malperfusion (odds ratio, 2.76; 95% confidence interval [CI], 1.94-3.93), cardiac malperfusion (odds ratio, 2.37; 95% CI, 1.34-4.17), renal malperfusion (odds ratio, 2.38; 95% CI, 1.23-4.61) and peripheral malperfusion (odds ratio, 1.95; 95% CI, 1.26-3.01). Any malperfusion (hazard ratio, 1.72; 95% CI, 1.21-2.43), cardiac malperfusion (hazard ratio, 1.89; 95% CI, 1.24-2.87) and gastrointestinal malperfusion (hazard ratio, 2.25; 95% CI, 1.18-4.26) were predictors of late mortality. Malperfusion was associated with significantly poorer survival at 1, 3, and 5 years (95.0% ± 0.9% vs 88.7% ± 1.9%, 90.1% ± 1.3% vs 84.0% ± 2.4%, and 85.4% ± 1.7% vs 80.8% ± 2.7%; log rank P = .009). CONCLUSIONS: Malperfusion has a significant influence on early and late outcomes in ATAAD surgery. Management of preoperative malperfusion remains a major challenge in reducing mortality associated with surgical treatment of ATAAD.
引用
- Zindovic I, Gudbjartsson T, Ahlsson A, et al. Malperfusion in acute type A aortic dissection: An update from the Nordic Consortium for Acute Type A Aortic Dissection. J Thorac Cardiovasc Surg. 2018. PMID: 30578066. doi:10.1016/j.jtcvs.2018.10.134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。